Brainlab announces UK symposia on Novalis Tx radiosurgery platform

23 April 2010

Image-guided technology developer Brainlab is inviting key UK clinicians and healthcare professionals to a series of clinical symposia on 27 April in Bristol, 28 April in Sheffield and 29 April in London at which international experts will present on their clinical experiences using the Novalis Tx radiosurgery platform. This will be a key opportunity to find out more about its power and versatility.

As one of the world’s most advanced radiosurgery platforms, Novalis Tx offers flexible treatment options for radiosurgery and radiotherapy and enables hospital staff to offer personalised treatment based on patients’ specific needs, from frameless and frame-based treatment of cranial indications to extra-cranial treatment of spine, lung and liver indications.

“Our technology helps increase patient access to improved, more consistent and more efficient treatment,” says David James, Area Sales Manager, Brainlab Ltd. “With the Novalis Tx radiosurgery platform, treatments that would have taken up to an hour or more using other techniques can be completed in just minutes, with equal accuracy.”

“We look forward to expanding the reach of Novalis Tx radiosurgery as the platform becomes established across the UK,” he said.

Many centres in Europe, the US, India and Asia are already treating a wide variety of cancers and neurological disorders with the Novalis Tx radiosurgery platform, including lung cancer, head and neck cancer, liver cancer, brain tumours, spine tumours and trigeminal neuralgia, a debilitating nerve disorder that triggers intense facial pain. Treatment involves shaping the radiation beam to the tumour or lesion, to help ensure that the prescribed treatment dose is delivered and healthy tissue is protected.

For more information on the Novalis Tx radiosurgery symposia please visit: www.brainlab.com/download/pdf/NTxClinicalEvening_April_invite.pdf